Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Clin North Am. 2013 Oct;93(5):1217-25. doi: 10.1016/j.suc.2013.06.001. Epub 2013 Jul 13.

Clinical outcomes of biologic mesh: where do we stand?

Author information

1
Department of Surgery, UCSF, 513 Parnassus Avenue, Room S-301, Box 0104, San Francisco, CA 94143-0104, USA. Electronic address: Hobart.Harris@ucsfmedctr.org.

Abstract

After review and evaluation of current clinical data, including significant wound complications, a noteworthy failure rate at 1 year, and high product costs, it is difficult to support the continued use of biologic meshes in incisional hernia repair outside of well-designed and rigorously conducted clinical trials. An industry-sponsored, publicly available registry of biologic prosthetic use for ventral hernia repairs is needed. This straightforward mandate, if properly constructed and implemented, would significantly expand knowledge regarding how these intriguing biomaterials are used and their overall clinical efficacy, thus yielding a more robust basis for the continued use of biologic prosthetics in hernia repair than is currently available.

KEYWORDS:

Allograft; Efficacy; Prosthetics; Xenograft

PMID:
24035084
DOI:
10.1016/j.suc.2013.06.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center